Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond L Benza

Showing results (41-50 of 210) with videos related to

Pageof 21
Sort By:
Pulmonary Circulation|July 24, 2018
Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertensionAditya A Joshi, Ryan Davey, Youlan Rao, et al.
Pulmonary Circulation|May 11, 2013
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertensionAmresh Raina, James C Coons, Manreet Kanwar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 21, 2013
Harvest of pulmonary artery endothelial cells from patients undergoing right heart catheterizationJonathan B Pollett, Raymond L Benza, Srinivas Murali, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 10, 2011
The role of fibrinolytic genes and proteins in the development of allograft vascular diseaseRaymond L Benza, Michael J Passineau, Peter G Anderson, et al.
Pulmonary Circulation|June 10, 2017
MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertensionErin M Faight, Kostas Verdelis, Lee Zourelias, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantationDaniel R Goldstein, Christopher S Coffey, Raymond L Benza, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2020
Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical TrialsJacqueline V Scott, Christine E Garnett, Manreet K Kanwar, et al.
Chest|April 12, 2008
Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentanRaymond L Benza, Barry K Rayburn, Jose A Tallaj, et al.
Journal of Cardiac Failure|May 13, 2014
Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertensionBarbro Kjellström, Robert P Frantz, Raymond L Benza, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentanRaymond L Benza, Sanjay Mehta, Anne Keogh, et al.
Pageof 21

Showing results (41-50 of 210) with videos related to

Sort By:
Pageof 21
Pulmonary Circulation|July 24, 2018
Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertensionAditya A Joshi, Ryan Davey, Youlan Rao, et al.
Pulmonary Circulation|May 11, 2013
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertensionAmresh Raina, James C Coons, Manreet Kanwar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 21, 2013
Harvest of pulmonary artery endothelial cells from patients undergoing right heart catheterizationJonathan B Pollett, Raymond L Benza, Srinivas Murali, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 10, 2011
The role of fibrinolytic genes and proteins in the development of allograft vascular diseaseRaymond L Benza, Michael J Passineau, Peter G Anderson, et al.
Pulmonary Circulation|June 10, 2017
MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertensionErin M Faight, Kostas Verdelis, Lee Zourelias, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantationDaniel R Goldstein, Christopher S Coffey, Raymond L Benza, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2020
Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical TrialsJacqueline V Scott, Christine E Garnett, Manreet K Kanwar, et al.
Chest|April 12, 2008
Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentanRaymond L Benza, Barry K Rayburn, Jose A Tallaj, et al.
Journal of Cardiac Failure|May 13, 2014
Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertensionBarbro Kjellström, Robert P Frantz, Raymond L Benza, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentanRaymond L Benza, Sanjay Mehta, Anne Keogh, et al.
Pageof 21